BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15277615)

  • 1. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
    Bian L; Yang JD; Guo TW; Sun Y; Duan SW; Chen WY; Pan YX; Feng GY; He L
    Neurology; 2004 Jul; 63(2):241-5. PubMed ID: 15277615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease.
    Edland SD
    J Mol Neurosci; 2004; 23(3):213-7. PubMed ID: 15181249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE).
    Edland SD; Wavrant-De Vriesé F; Compton D; Smith GE; Ivnik R; Boeve BF; Tangalos EG; Petersen RC
    Neurosci Lett; 2003 Jul; 345(1):21-4. PubMed ID: 12809979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.
    Cook DG; Leverenz JB; McMillan PJ; Kulstad JJ; Ericksen S; Roth RA; Schellenberg GD; Jin LW; Kovacina KS; Craft S
    Am J Pathol; 2003 Jan; 162(1):313-9. PubMed ID: 12507914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in a haplotype block spanning IDE influences Alzheimer disease.
    Prince JA; Feuk L; Gu HF; Johansson B; Gatz M; Blennow K; Brookes AJ
    Hum Mutat; 2003 Nov; 22(5):363-71. PubMed ID: 14517947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between polymorphisms of the insulin-degrading enzyme gene and late-onset Alzheimer disease.
    Wang S; He F; Wang Y
    J Geriatr Psychiatry Neurol; 2015 Jun; 28(2):94-8. PubMed ID: 25414272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between the insulin degrading enzyme gene and Alzheimer's disease in a Japanese population.
    Sakai A; Ujike H; Nakata K; Takehisa Y; Imamura T; Uchida N; Kanzaki A; Yamamoto M; Fujisawa Y; Okumura K; Kuroda S
    Am J Med Genet B Neuropsychiatr Genet; 2004 Feb; 125B(1):87-91. PubMed ID: 14755451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease.
    Ertekin-Taner N; Allen M; Fadale D; Scanlin L; Younkin L; Petersen RC; Graff-Radford N; Younkin SG
    Hum Mutat; 2004 Apr; 23(4):334-42. PubMed ID: 15024728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.
    Nowotny P; Hinrichs AL; Smemo S; Kauwe JS; Maxwell T; Holmans P; Hamshere M; Turic D; Jehu L; Hollingworth P; Moore P; Bryden L; Myers A; Doil LM; Tacey KM; Gibson AM; McKeith IG; Perry RH; Morris CM; Thal L; Morris JC; O'Donovan MC; Lovestone S; Grupe A; Hardy J; Owen MJ; Williams J; Goate A
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jul; 136B(1):62-8. PubMed ID: 15858813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population.
    Vepsäläinen S; Parkinson M; Helisalmi S; Mannermaa A; Soininen H; Tanzi RE; Bertram L; Hiltunen M
    J Med Genet; 2007 Sep; 44(9):606-8. PubMed ID: 17496198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between two single nucleotide polymorphisms within the insulin-degrading enzyme gene and Alzheimer's disease in a Chinese Han population.
    Cui PJ; Cao L; Wang Y; Deng YL; Xu W; Wang G; Zhang Y; Zheng L; Fei QZ; Zhang T; Chen SD
    J Clin Neurosci; 2012 May; 19(5):745-9. PubMed ID: 22502914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease.
    Boussaha M; Hannequin D; Verpillat P; Brice A; Frebourg T; Campion D
    Neurosci Lett; 2002 Aug; 329(1):121-3. PubMed ID: 12161276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of TOMM40 polymorphisms with late-onset Alzheimer's disease in a Northern Han Chinese population.
    Ma XY; Yu JT; Wang W; Wang HF; Liu QY; Zhang W; Tan L
    Neuromolecular Med; 2013 Jun; 15(2):279-87. PubMed ID: 23288655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
    Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
    Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined risk effects of IDE and NEP gene variants on Alzheimer disease.
    Vepsäläinen S; Helisalmi S; Mannermaa A; Pirttilä T; Soininen H; Hiltunen M
    J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1268-70. PubMed ID: 19864659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE.
    Björk BF; Katzov H; Kehoe P; Fratiglioni L; Winblad B; Prince JA; Graff C
    Neurobiol Aging; 2007 Sep; 28(9):1374-80. PubMed ID: 16876916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.
    Nicodemus KK; Stenger JE; Schmechel DE; Welsh-Bohmer KA; Saunders AM; Roses AD; Gilbert JR; Vance JM; Haines JL; Pericak-Vance MA; Martin ER
    Neurogenetics; 2004 Dec; 5(4):201-8. PubMed ID: 15455263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.
    Bertram L; Blacker D; Mullin K; Keeney D; Jones J; Basu S; Yhu S; McInnis MG; Go RC; Vekrellis K; Selkoe DJ; Saunders AJ; Tanzi RE
    Science; 2000 Dec; 290(5500):2302-3. PubMed ID: 11125142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.